SEC Form 4 · accession 0001140361-17-025248
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary W Pace
Director
Period of report
Jun 14, 2017
Accepted (ET)
Jun 16, 2017 · 11:20 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Jun 14, 2017 | M | 1,730 | $33.70 | A | 99,317 | D | |
| ResMed Common Stock | Jun 14, 2017 | S | 1,730 | $76.00 | D | 97,587 | D | |
| ResMed Common Stock | Jun 15, 2017 | M | 22,660 | $33.70 | A | 120,247 | D | |
| ResMed Common Stock | Jun 15, 2017 | S | 22,660 | $76.00 | D | 97,587 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $33.70 | Jun 14, 2017 | M | 1,730 | D | Nov 11, 2011 | Nov 11, 2017 | ResMed Common Stock | 1,730 | 22,660 | D |
| ResMed Common Stock OptionsF2 | $33.70 | Jun 15, 2017 | M | 22,660 | D | Nov 11, 2011 | Nov 11, 2017 | ResMed Common Stock | 22,660 | 0 | D |
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 plan.
- F2Represents date options first became exercisable. Options vest one full year following the grant date.